The Cheapest Sector to Own Today

After a poor outing in 2016, biotech and pharmaceutical names are showing signs of life. Since December 30,  the iShares NASDAQ Biotech ETF (IBB) ran from 265 to a high of 303 (+14%) and the SPDR S&P Biotech ETF (XBI) shot from 59 to a high of 72 or +22%. And while both indexes have…

I’m Serious

I’m 100% serious about finding a big winner (or three) in the cannabis boom. The numbers are so big there has to be something… Something soon too. California is set to approve recreational cannabis in just three weeks. That alone will be worth $6.4 billion in annual sales. There are four more states where it’s…